Interaction between RAAS inhibitors and ACE2 in the context of COVID-19.

Jun 1, 2021·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Inah Maria D PeclyCibele I S Rodrigues

Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.

May 31, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Yusuf Oloruntoyin AyipoMohd Nizam Mordi

Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.

Jun 17, 2021·Phytotherapy Research : PTR·Myriam MerarchiManoj Garg

Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm.

Nov 14, 2020·Hellenic Journal of Cardiology : HJC = Hellēnikē Kardiologikē Epitheōrēsē·Filippos TriposkiadisHarisios Boudoulas

A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.

Jun 29, 2021·Frontiers in Pharmacology·Elizabeth M Sajdel-Sulkowska

COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances.

Jul 17, 2021·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Annemarie J F WestheimRonit Shiri-Sverdlov

Potential mechanisms of the anti-hypertensive effects of RVPSL on spontaneously hypertensive rats using non-targeted serum metabolomics.

Aug 3, 2021·Food & Function·Zhipeng YuJianrong Li

COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2.

Jun 27, 2021·The Journal of Physiology·Nina L StuteAbigail S L Stickford

Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study.

Sep 14, 2021·Journal of Biomolecular Structure & Dynamics·Gérard Vergoten, Christian Bailly

Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation.

Oct 17, 2021·Molecular and Cellular Biochemistry·Santoshi SahuRamesh K Goyal

Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis.

Dec 21, 2021·Frontiers in Pharmacology·Yingying YangXiaolin Tong

Anti-Inflammatory Drugs and the Renin-Angiotensin-Aldosterone System: Current Knowledge and Potential Effects on Early SARS-CoV-2 Infection

Oct 12, 2020·Virus Research·Iris Louise N Cabbab, Rafael Vincent M Manalo

A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).

May 12, 2020·Infectious Disorders Drug Targets·Suraj N MaliAtul R Chopade

The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions

Jul 13, 2020·Life Sciences·Tapan BehlSandeep Arora

Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation.

Feb 24, 2022·Advanced Biology·Junjie GaoJia Liu

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Interaction between RAAS inhibitors and ACE2 in the context of COVID-19.

Abstract

References

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients

Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression

Hypertension: renin-angiotensin-aldosterone system alterations

Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure

COVID-19 and the cardiovascular system.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Citations

The Role of Data Registries in the Time of COVID-19

Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.

Reply to: "Reporting of all cardiac medications and their outcome in COVID-19"

Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety

Is Sex a Determinant of COVID-19 Infection? Truth or Myth?

Mechanisms by which angiotensin-receptor blockers increase ACE2 levels.

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.

Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications.

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

COVID-19 and the Kidneys: An Update

Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data

Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection

The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis.

Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.

Drugs acting on the renin-angiotensin system and SARS-CoV-2.

Manipulation of ACE2 expression in COVID-19.

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives

Covid-19 and Diabetes: A Complex Bidirectional Relationship.

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.

Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?

Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review

Potential SARS-CoV-2 main protease inhibitors.

Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature.

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.

Drugs acting on renin angiotensin system and use in ill patients with COVID-19

Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis

Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2

A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.